## BD's Strategic Move in Immunotherapy: Partnering with Penn's Institute to Transform Immune Research
**Becton, Dickinson and Company** (ticker: BDX) has unveiled a significant partnership with the University of Pennsylvania's Institute for Immunology and Immune Health to advance next-generation immune profiling capabilities. The collaboration centers on leveraging BD's advanced flow cytometry technology to conduct a comprehensive immune analysis study encompassing 1,000 participants, with the goal of examining more than 30 cellular functions within whole blood samples and identifying phospho
**Becton, Dickinson and Company** (ticker: BDX) has unveiled a significant partnership with the University of Pennsylvania's Institute for Immunology and Immune Health to advance next-generation immune profiling capabilities. The collaboration centers on leveraging BD's advanced flow cytometry technology to conduct a comprehensive immune analysis study encompassing 1,000 participants, with the goal of examining more than 30 cellular functions within whole blood samples and identifying phospho